Tarsus Pharmaceuticals Inc
NASDAQ:TARS

Watchlist Manager
Tarsus Pharmaceuticals Inc Logo
Tarsus Pharmaceuticals Inc
NASDAQ:TARS
Watchlist
Price: 82.51 USD 0.46% Market Closed
Market Cap: 3.5B USD

Intrinsic Value

The intrinsic value of one TARS stock under the Base Case scenario is 84.44 USD. Compared to the current market price of 82.51 USD, Tarsus Pharmaceuticals Inc is Undervalued by 2%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

TARS Intrinsic Value
84.44 USD
Undervaluation 2%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Tarsus Pharmaceuticals Inc

What is Valuation History?
Ask AI Assistant
What other research platforms think about TARS?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is TARS valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Tarsus Pharmaceuticals Inc.

Explain Valuation
Compare TARS to

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about TARS?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Tarsus Pharmaceuticals Inc

Current Assets 501.7m
Cash & Short-Term Investments 401.8m
Receivables 74.3m
Other Current Assets 25.5m
Non-Current Assets 32.9m
Long-Term Investments 3m
PP&E 16m
Intangibles 7.6m
Other Non-Current Assets 6.3m
Current Liabilities 117.1m
Accounts Payable 40.6m
Accrued Liabilities 76.4m
Non-Current Liabilities 82.4m
Long-Term Debt 72.3m
Other Non-Current Liabilities 10.1m
Efficiency

Free Cash Flow Analysis
Tarsus Pharmaceuticals Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Tarsus Pharmaceuticals Inc

Revenue
366.1m USD
Cost of Revenue
-24.7m USD
Gross Profit
341.4m USD
Operating Expenses
-428.8m USD
Operating Income
-87.4m USD
Other Expenses
6.3m USD
Net Income
-81.2m USD
Fundamental Scores

TARS Profitability Score
Profitability Due Diligence

Tarsus Pharmaceuticals Inc's profitability score is 27/100. The higher the profitability score, the more profitable the company is.

ROIC is Increasing
Exceptional Gross Margin
Strong 3Y Average Gross Margin
Operating Margin is Increasing
27/100
Profitability
Score

Tarsus Pharmaceuticals Inc's profitability score is 27/100. The higher the profitability score, the more profitable the company is.

TARS Solvency Score
Solvency Due Diligence

Tarsus Pharmaceuticals Inc's solvency score is 71/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Negative Net Debt
Low D/E
71/100
Solvency
Score

Tarsus Pharmaceuticals Inc's solvency score is 71/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

TARS Price Targets Summary
Tarsus Pharmaceuticals Inc

Wall Street analysts forecast TARS stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for TARS is 88.63 USD with a low forecast of 51.51 USD and a high forecast of 105 USD.

Lowest
Price Target
51.51 USD
38% Downside
Average
Price Target
88.63 USD
7% Upside
Highest
Price Target
105 USD
27% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Tarsus Pharmaceuticals Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for TARS is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

TARS Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one TARS stock?

The intrinsic value of one TARS stock under the Base Case scenario is 84.44 USD.

Is TARS stock undervalued or overvalued?

Compared to the current market price of 82.51 USD, Tarsus Pharmaceuticals Inc is Undervalued by 2%.

Back to Top